These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

862 related items for PubMed ID: 19414428

  • 1. Hyperthermic isolated perfusion with tumor necrosis factor-alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcoma: the experience of the Italian Society of Integrated Locoregional Treatment in Oncology (SITILO).
    Di Filippo F, Giacomini P, Rossi CR, Santinami M, Garinei R, Anzà M, Deraco M, Botti C, Perri P, Cavaliere F, Di Angelo P, Sofra C, Sperduti I, Pasqualoni R, Di Filippo S, Corrias F, Armenti A, Ferraresi V.
    In Vivo; 2009; 23(2):363-7. PubMed ID: 19414428
    [Abstract] [Full Text] [Related]

  • 2. Hyperthermic isolated perfusion with low-dose tumor necrosis factor alpha and doxorubicin for the treatment of limb-threatening soft tissue sarcomas.
    Rossi CR, Mocellin S, Pilati P, Foletto M, Campana L, Quintieri L, De Salvo GL, Lise M.
    Ann Surg Oncol; 2005 May; 12(5):398-405. PubMed ID: 15915374
    [Abstract] [Full Text] [Related]

  • 3. Doxorubicin in isolation limb perfusion in the treatment of advanced limb soft tissue sarcoma.
    Di Filippo F, Garinei R, Anzà M, Cavaliere F, Giannarelli D, Cagol PP, Rossi CR, Santinami M, Deraco M, Botti C, Perri P, Di Filippo S, Piarulli L, Bruno P.
    J Exp Clin Cancer Res; 2003 Dec; 22(4 Suppl):81-7. PubMed ID: 16767912
    [Abstract] [Full Text] [Related]

  • 4. Limb salvage by neoadjuvant isolated perfusion with TNFalpha and melphalan for non-resectable soft tissue sarcoma of the extremities.
    Lejeune FJ, Pujol N, Liénard D, Mosimann F, Raffoul W, Genton A, Guillou L, Landry M, Chassot PG, Chiolero R, Bischof-Delaloye A, Leyvraz S, Mirimanoff RO, Bejkos D, Leyvraz PF.
    Eur J Surg Oncol; 2000 Nov; 26(7):669-78. PubMed ID: 11078614
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Hyperthermic isolation limb perfusion with TNFalpha in the treatment of in-transit melanoma metastasis.
    Di Filippo F, Rossi CR, Santinami M, Cavaliere F, Garinei R, Anzà M, Perri P, Botti C, Di Angelo P, Pasqualoni R, Di Filippo S.
    In Vivo; 2006 Nov; 20(6A):739-42. PubMed ID: 17203758
    [Abstract] [Full Text] [Related]

  • 9. Long-term results of tumor necrosis factor alpha- and melphalan-based isolated limb perfusion in locally advanced extremity soft tissue sarcomas.
    Deroose JP, Eggermont AM, van Geel AN, Burger JW, den Bakker MA, de Wilt JH, Verhoef C.
    J Clin Oncol; 2011 Oct 20; 29(30):4036-44. PubMed ID: 21931039
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in patients with locally advanced soft tissue sarcomas: treatment response and clinical outcome related to changes in proliferation and apoptosis.
    Plaat BE, Molenaar WM, Mastik MF, Koudstaal J, van den Berg E, Koops HS, Hoekstra HJ.
    Clin Cancer Res; 1999 Jul 20; 5(7):1650-7. PubMed ID: 10430064
    [Abstract] [Full Text] [Related]

  • 12. Isolated limb perfusion with tumor necrosis factor alpha and melphalan for locally advanced soft tissue sarcoma: the value of adjuvant radiotherapy.
    Thijssens KM, van Ginkel RJ, Pras E, Suurmeijer AJ, Hoekstra HJ.
    Ann Surg Oncol; 2006 Apr 20; 13(4):518-24. PubMed ID: 16485147
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Isolation limb perfusion with tumor necrosis factor alpha and chemotherapy for advanced extremity soft tissue sarcomas.
    Eggermont AM, Schraffordt Koops H, Klausner JM, Liénard D, Kroon BB, Schlag PM, Ben-Ari G, Lejeune FJ.
    Semin Oncol; 1997 Oct 20; 24(5):547-55. PubMed ID: 9344321
    [Abstract] [Full Text] [Related]

  • 19. [Tumor necrosis factor α and melfalan-based hyperthermic isolated limb perfusion in locally advanced extremity soft tissue sarcomas and melanomas].
    Alegre JF, Duarte M, Sureda González M, Bretcha Boix P, Dussan C, Ballester A, Crespo A, Brugarolas Masllorens A.
    Cir Esp; 2012 Feb 20; 90(2):114-20. PubMed ID: 22225611
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 44.